rcca-header
Clinical Trials

A Phase 1b/2, Open-Label, Randomized Study of Daratumumab Administered in Combination with Atezolizumab Compared with Atezolizumab Alone in Subjects with Previously Treated Advanced or metastatic Non-Small Cell Lung Cancer

Type of Cancer
Lung
Phase
Division (Location)
Bethesda, MD
Study ID
NCT#
Brief Description
A Phase 1b/2, Open-Label, Randomized Study of Daratumumab Administered in Combination with Atezolizumab Compared with Atezolizumab Alone in Subjects with Previously Treated Advanced or metastatic Non-Small Cell Lung Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.